Medline’s IPO underscores broad investor appetite for a sleepy corner of the healthcare business

Last Updated: Dec. 17, 2025 at 4:43 p.m. ET
First Published: Dec. 17, 2025 at 4:07 p.m. ET

Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other medical and surgical products.

Medline’s stock MDLN soared 41% above its IPO price on Wednesday. That was the best offer-to-close price performance since diagnostics company BillionToOne BLLN rose 82% on its first day of trading Nov. 6.